Current stock page

Stock Analysis

Scholar Rock Holding Corporation (SRRK) Stock Analysis

Scholar Rock Holding Corporation (SRRK) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

SRRK Stock Analysis Summary

Scholar Rock Holding Corporation (SRRK) currently has an AIQ Score of 39/100, indicating a bearish setup. Momentum is the strongest factor at 54/100. Quality is the weakest current factor at 14/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

SRRK at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$43.21
AIQ Score39/100
Overall ViewBearish
Technical Analysis ConsensusSell
Market Cap$5.72B
P/E Ratio (TTM)-13.42
Forward P/E—
EPS (Q3 FY2026)-$0.81
Revenue (Q3 FY2026)$570K
Dividend Yield (TTM)0.00%
Beta1.12
Volume623.56K
52-week range$29.35-$61.76
RSI 1445.31
50-Day SMA$46.13
200-Day SMA$48.24
Analyst Price Target$71.30
Next EarningsMar 2, 2027
As of Nov 13, 2026 · Market close

SRRKScholar Rock Holding Corporation

Healthcare / Biotechnology

Low Priority

Above Peers

BearishEdge 6/10
$43.21+$0.05 (+0.10%)

Latest quote

  • Momentum
    54
  • Value
    —
  • Quality
    14
  • Risk resilience
    52
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

SRRK Stock Analysis Summary

Scholar Rock Holding Corporation (SRRK) currently has an AIQ Score of 39/100, indicating a bearish setup. Momentum is the strongest factor at 54/100. Quality is the weakest current factor at 14/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bearish

In a bearish regime, SRRK has AIQ Score of 39/100 with Momentum base of 54/100 and fading Quality at 14/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (54/100) leads while Quality (14/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 0.10% stock move · SRRK classified in Biotechnology.

Current Evidence

BearishSRRK is in a bearish AIQ regime; Momentum is the strongest visible factor at 54/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is SRRK Bullish or Bearish Right Now?

SRRK currently has a bearish overall setup. Momentum is the strongest factor at 54/100, while Quality is weakest at 14/100. The current evidence suggests a bearish setup.

Bull Case
  • - Analyst target implies +65.03% upside from the latest quote.
Bear Case
  • - Price is -10.43% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (26 vs 14).

Current Consensus

SRRK's Technical Analysis Consensus is currently Sell, with 14 buy, 6 neutral, and 26 sell votes. SRRK's 14-day RSI is 45.31, which places the stock in a neutral momentum range. SRRK's beta is 1.12, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in SRRK?

The largest recent change in SRRK is Quality moving down by 15.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
-6.0
Momentum
-1.0
Quality
-15.0
Risk
-3.0

What Would Change the SRRK Outlook?

The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

SRRK Decision Framework

Public evidence layers, setup checks, and risk context for Scholar Rock Holding Corporation.

Scholar Rock Holding Corporation (SRRK) Stock Analysis

Scholar Rock Holding Corporation has an AIQ Score of 39/100 in a Bearish regime. Momentum is strongest at 54/100. Beta is 1.12, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextSRRK is in a Bearish AIQ regime with score 39/100.
Signal ConflictThe primary conflict is that momentum leads at 54/100 while quality lags at 14/100.
Factor EvidenceMomentum 54/100 · Quality 14/100 · Risk 52/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthWait

Momentum is the strongest factor at 54/100.

TimingWait

Momentum is 54/100 and RSI (14) is 45.3.

Regime fitFail

SRRK is in a Bearish regime at 39/100.

Risk controlWait

Risk factor is 52/100 with beta 1.12 and annual volatility 57.45%.

ConflictWait

Current conflict: momentum leads at 54/100 while quality lags at 14/100.

AIQ Score
39/100
Price
$43.21
Beta
1.12
RSI (14)
45.3

SRRK Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

SRRK Fundamentals

SRRK valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$570K
Net income
-$107.24M
Free cash flow
-$81.91M
View full SRRK fundamental analysis

SRRK Technical Analysis

SRRK technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Sell
RSI 14
45.31
Price vs SMA-50
-6.34%
View full SRRK technical analysis

SRRK Stock Catalysts

Track SRRK earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Mar 2, 2027
Analyst target
$71.30
News items
5
View SRRK earnings and stock catalysts

SRRK Dividend Analysis

SRRK dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View SRRK dividend history and analysis

SRRK Financial Data

SRRK revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$570K
EPS
-$0.81
Periods
8
View SRRK financials

SRRK Risk Analysis

SRRK volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.12
Risk score
52/100
1Y volatility
57.45%
View SRRK risk analysis

SRRK Stock News

SRRK stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 15, 2026
Sentiment
—
Read SRRK stock news

SRRK vs Biotechnology Peers

Current peer cohort: SRRK · STOK · SYRE · TARS · TGTX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
SRRK
Current stock
39/100—54/10052/1000.8457.45%Current
STOK
Stoke Therapeutics, Inc.
42/10022/10047/10059/1000.2353.19%SRRK vs STOK
SYRE
Spyre Therapeutics, Inc.
64/10044/10081/10053/1002.5766.66%SRRK vs SYRE
TARS
Tarsus Pharmaceuticals, Inc.
65/10075/10076/10059/1000.3645.02%SRRK vs TARS
TGTX
TG Therapeutics, Inc.
76/10065/10093/10063/1001.7446.06%SRRK vs TGTX
Pairwise Compare links: STOK · SYRE · TARS · TGTXSRRK vs STOKSRRK vs SYRESRRK vs TARSSRRK vs TGTXCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a SRRK stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for SRRK: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-13.42
As of Nov 13, 2026
Revenue growth
—
Gross margin
-8235.96%
Current debt / equity
1.2
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$570K
Quarter net income
-$107.24M
Quarter free cash flow
-$81.91M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Mixed
RSI 14
45.31
MACD
0.19

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
52/100
Beta
1.12
Annual volatility
57.45%
Max drawdown
-34.04%

SRRK Stock FAQ

What is SRRK stock price today?

Scholar Rock Holding Corporation's current stock price is $43.21. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is SRRK bullish or bearish right now?

SRRK's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is SRRK's market cap?

SRRK's market cap is $5.72B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is SRRK's current P/E ratio?

SRRK's current P/E ratio is -13.42 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is SRRK's RSI?

SRRK's 14-day RSI is 45.31 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is SRRK above its 50-day and 200-day moving averages?

SRRK is -6.34% from its 50-day SMA and -10.43% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is SRRK's next earnings date?

SRRK's next earnings date is currently listed as Mar 2, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does SRRK pay a dividend?

SRRK's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.